Glenn Pride, MD
Vascular & Interventional Radiology · Dallas, TXNPI 1295790012
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,139 of the $17,099 with a category attached, or 94.4%. Medical Device Business Services, Inc. accounts for 94.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $9,966 and has fallen 98.3% since, to $173 in 2025.
Across 22 payments — averaging $777.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$16K
- Johnson & Johnson$362
- Stryker$223
- Medtronic$205
- Penumbra, Inc.$135
- Microvention, Inc.$34
What the payments were for
- Consulting fees$16,13994%
- Food & beverage$9606%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 6 | $16,139 |
| Johnson & Johnson | 8 | $362 |
| Stryker | 4 | $223 |
| Medtronic | 2 | $205 |
| Penumbra, Inc. | 1 | $135 |
| Microvention, Inc. | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,099 in reported general payments places this provider in the 80th percentile of 299 vascular & interventional radiology providers in Texas.
See all vascular & interventional radiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 14 | $93 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Dallas
- Sanjeeva KalvaDallas$128K
- Aaron FrittsDallas$101K
- Dev BatraDallas$72K
- Stephen HumphreyDallas$63K
- Travis van MeterDallas$33K
- Steve HongDallas$28K
- Seung KimDallas$22K
- Orlando DiazHouston$611K
- Rahul ShethHouston$410K
- Miguel MonteroHouston$386K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.